GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Ending Cash Position

Glycorex Transplantation AB (NGM:GTAB B) Ending Cash Position : kr5.77 Mil (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Ending Cash Position?

Glycorex Transplantation AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr5.77 Mil.

Glycorex Transplantation AB's quarterly Ending Cash Position declined from Jun. 2024 (kr6.88 Mil) to Sep. 2024 (kr6.47 Mil) and declined from Sep. 2024 (kr6.47 Mil) to Dec. 2024 (kr5.77 Mil).

Glycorex Transplantation AB's annual Ending Cash Position declined from Dec. 2022 (kr32.63 Mil) to Dec. 2023 (kr12.89 Mil) and declined from Dec. 2023 (kr12.89 Mil) to Dec. 2024 (kr5.77 Mil).

Glycorex Transplantation AB Ending Cash Position Historical Data

The historical data trend for Glycorex Transplantation AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Ending Cash Position Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.30 42.13 32.63 12.89 5.77

Glycorex Transplantation AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.89 10.21 6.88 6.47 5.77

Glycorex Transplantation AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Glycorex Transplantation AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12.888+-7.123
=5.77

Glycorex Transplantation AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=6.471+-0.706
=5.77

Glycorex Transplantation AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Glycorex Transplantation AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Ending Cash Position
Comparable Companies
OSTO:ALZ OSTO:KAN XSAT:CURAS OSTO:MVIR XSAT:ABERA OSTO:ANNX OSTO:ALZCUR OSTO:ELIC OSTO:ACTI XSAT:BIOWKS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
O33:Germany
Address
Solvegatan 41, Lund, SWE, 223 70
Website
http://www.glycorex.se
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines